Skip to main content
TipRanks
Go Ultimate75% OFF

Austar Lifesciences Ltd. (6118) Financial Statements

1 Followers

Austar Lifesciences Ltd. Financial Overview

Austar Lifesciences Ltd.'s market cap is currently ¥258.85M. The company's EPS TTM is ¥0.03; its P/E ratio is 12.80; and it has a dividend yield of 1.52%. Austar Lifesciences Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.53B¥ 1.50B¥ 1.76B¥ 2.16B¥ 2.02B
Gross Profit¥ 293.27M¥ 301.22M¥ 336.05M¥ 488.80M¥ 479.01M
Operating Income¥ 54.15M¥ 35.18M¥ -29.99M¥ 116.37M¥ 311.92M
EBITDA¥ 92.28M¥ 87.88M¥ 25.15M¥ 159.79M¥ 148.54M
Net Income¥ 33.80M¥ 16.08M¥ -113.47M¥ 87.46M¥ 277.30M
Balance Sheet
Cash & Short-Term Investments¥ 276.59M¥ 167.81M¥ 173.76M¥ 148.13M¥ 219.74M
Total Assets¥ 2.13B¥ 2.08B¥ 2.16B¥ 2.39B¥ 2.04B
Total Debt¥ 343.82M¥ 401.95M¥ 496.20M¥ 336.55M¥ 155.22M
Net Debt¥ 67.23M¥ 235.15M¥ 332.43M¥ 202.92M¥ -43.22M
Total Liabilities¥ 1.30B¥ 1.29B¥ 1.38B¥ 1.51B¥ 1.26B
Stockholders' Equity¥ 822.90M¥ 791.41M¥ 773.01M¥ 896.94M¥ 786.58M
Cash Flow
Free Cash Flow¥ 99.74M¥ 78.31M¥ -133.59M¥ -155.25M¥ -204.02M
Operating Cash Flow¥ 128.24M¥ 98.81M¥ -62.65M¥ -37.93M¥ -103.45M
Investing Cash Flow¥ -15.58M¥ 4.43M¥ -54.47M¥ -153.14M¥ 65.02M
Financing Cash Flow¥ -42.76M¥ -101.32M¥ 147.12M¥ 125.30M¥ 59.35M

Currency in CNY

Austar Lifesciences Ltd. Earnings and Revenue History

-1.2B01.2B2.4B-12 %0 %12 %24 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Austar Lifesciences Ltd. Liabilities to Assets

01B2B3B40 %50 %60 %70 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Austar Lifesciences Ltd. Cash Flow

-200M-100M0100M200M201720182019202020212022202320242025OperatingInvestingFinancing

Austar Lifesciences Ltd. Forecast EPS vs Actual EPS

000000.10.1Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss